CGEM

CGEM Operating Income Growth

5.49%TTM

Period ending:

CGEM TTM Operating Income YoY %%
CGEM TTM Operating Income YoY %451.08%-324.63%
2020-12-312026-06-30

Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.

CGEM operating income growth history

Year-over-year operating income growth rate. The available trailing twelve months (ttm) series contains 23 observations from Dec 31, 2020 to Jun 30, 2026.

Cullinan Therapeutics Inc Operating Income Growth — Trailing twelve months (TTM)
Period endingOperating Income Growth
5.493%
-15.0403%
-22.7144%
-28.8654%
-27.7304%
-21.9493%
-3.0509%
-5.131%
-12.9099%
-249.5622%
-232.1062%
-224.7031%
-205.4666%
212.3217%
312.8616%
327.6346%
376.0089%
-90.9008%
-12.6278%
-73.7085%
-76.9394%
-135.9421%
-170.925%

Compare operating income growth

All CGEM financial metrics · CGEM stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.